Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
Eagle Pharmaceuticals, Inc.
Woodcliff Lake, New Jersey
We hereby consent to the incorporation by reference in this Registration Statement of our report dated March 7, 2020, relating to the consolidated financial statements of Eagle Pharmaceuticals, Inc. appearing in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021.
| /s/ BDO USA, LLP | |
| Woodbridge, New Jersey |
March 25, 2022